Apr 11 |
Are Regeneron's Legal Troubles — And Six-Week Slide — A Buying Opportunity?
|
Apr 11 |
Dow Jones Lower Despite PPI Inflation Relief; Nvidia, Microsoft Price Targets Raised
|
Apr 11 |
These Stocks Are Moving the Most Today: CarMax, Fastenal, Alpine Immune, Nike, Robinhood, Constellation Brands, and More
|
Apr 11 |
US sues Regeneron, alleging false price reporting on Eylea
|
Apr 10 |
DOJ files complaint against Regeneron over Eylea Medicare pricing
|
Apr 10 |
US Justice department files complaint against Regeneron, alleges fraudulent drug pricing
|
Apr 10 |
UPDATE 1-US Justice department files complaint against Regeneron, alleges fraudulent drug pricing
|
Apr 10 |
An Intrinsic Calculation For Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Suggests It's 47% Undervalued
|
Apr 9 |
11 Best Biotech ETFs To Buy
|
Apr 7 |
Linvoseltamab Pivotal Data Presented at AACR Reinforce High Response Rate that Deepens Over Time in Patients with Heavily Pre-Treated Multiple Myeloma
|